MIM
CLSD

Monashee Investment Management’s Clearside Biomedical CLSD Stock Holding History

Monashee Investment Management’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5,000
Closed -$671K – 92
2016
Q4 		$671K Buy
+5,000
New +$1.26M 0.33% 62
2016
Q2 		– Hold
0
– – – 53

Other funds holding CLSD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Monashee Investment Management's CLSD Position: Q1 2017 in Review

Monashee Investment Management sold out of Clearside Biomedical (CLSD) in Q1 2017, closing a stake of 5,000 shares — an estimated $671K sold.

Monashee Investment Management first reported a position in CLSD in Q4 2016 and held it in 1 quarter. The position peaked at $671K in Q4 2016. 59 funds tracked by Wall St. Rank hold CLSD as of Q1 2017.

  • Monashee Investment Management reported no remaining Clearside Biomedical position as of Q1 2017 after selling out during the quarter.
  • Monashee Investment Management sold 5,000 Clearside Biomedical shares in Q1 2017, an estimated $671K.
  • Monashee Investment Management first reported a position in Clearside Biomedical in Q4 2016 and held it in 1 quarter.
  • Monashee Investment Management's Clearside Biomedical position peaked at $671K in Q4 2016.
  • 59 funds tracked by Wall St. Rank held Clearside Biomedical as of Q1 2017.

Based on Monashee Investment Management's 13F filing for Q1 2017, filed 12 May 2017.